Adslot seems to be going from strength to strength. They've signed up some pretty big global web publishers and the facilitate acquisition should provide the demand side. They're also trading cheaply, at prices not seen since last October.
Re: ACR - Acrux
I owned Acrux but recently sold my stake on the back of the recent bad news. I've described my experience in more detail here. I too was worried about the discretionary nature of its testosterone replacement therapy. It'll be interesting to see if the recent negative publicity...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.